loading
Precedente Chiudi:
$605.61
Aprire:
$606.89
Volume 24 ore:
244.19K
Relative Volume:
0.25
Capitalizzazione di mercato:
$65.95B
Reddito:
$14.09B
Utile/perdita netta:
$4.50B
Rapporto P/E:
15.47
EPS:
39.28
Flusso di cassa netto:
$2.96B
1 W Prestazione:
-0.49%
1M Prestazione:
+6.01%
6M Prestazione:
-26.71%
1 anno Prestazione:
-36.48%
Intervallo 1D:
Value
$602.09
$611.04
Intervallo di 1 settimana:
Value
$542.44
$615.61
Portata 52W:
Value
$525.99
$1,211.20

Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile

Name
Nome
Regeneron Pharmaceuticals Inc
Name
Telefono
(914) 847-7000
Name
Indirizzo
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
Name
Dipendente
15,158
Name
Cinguettio
@regeneron
Name
Prossima data di guadagno
2025-02-04
Name
Ultimi documenti SEC
Name
REGN's Discussions on Twitter

Confronta REGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
607.27 65.95B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
504.46 127.64B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
ARGX
Argen X Se Adr
655.81 37.92B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
269.52 32.98B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
253.49 26.89B 3.81B -644.79M -669.77M -6.24

Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-04-22 Ripresa Cantor Fitzgerald Overweight
2025-02-05 Aggiornamento Leerink Partners Market Perform → Outperform
2025-01-16 Downgrade UBS Buy → Neutral
2024-12-10 Ripresa BofA Securities Underperform
2024-11-15 Iniziato Wolfe Research Outperform
2024-11-14 Iniziato Citigroup Neutral
2024-09-24 Downgrade Leerink Partners Outperform → Market Perform
2024-03-12 Iniziato Bernstein Outperform
2024-01-12 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-11-09 Iniziato Deutsche Bank Hold
2023-11-03 Aggiornamento Raymond James Mkt Perform → Outperform
2023-08-21 Aggiornamento Canaccord Genuity Hold → Buy
2023-08-21 Reiterato Oppenheimer Perform
2023-06-28 Downgrade Canaccord Genuity Buy → Hold
2023-03-27 Aggiornamento SVB Securities Market Perform → Outperform
2023-03-24 Aggiornamento Jefferies Hold → Buy
2023-03-23 Aggiornamento Raymond James Underperform → Mkt Perform
2023-01-30 Aggiornamento Cowen Market Perform → Outperform
2023-01-20 Aggiornamento JP Morgan Neutral → Overweight
2022-10-26 Downgrade Raymond James Mkt Perform → Underperform
2022-10-17 Downgrade Evercore ISI Outperform → In-line
2022-09-09 Aggiornamento Jefferies Underperform → Hold
2022-09-09 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2022-07-25 Downgrade SVB Leerink Outperform → Mkt Perform
2022-07-13 Iniziato Cantor Fitzgerald Neutral
2022-06-06 Iniziato Jefferies Underperform
2022-05-23 Iniziato SVB Leerink Outperform
2022-01-05 Downgrade BofA Securities Neutral → Underperform
2022-01-03 Aggiornamento Bernstein Mkt Perform → Outperform
2021-12-15 Downgrade Bernstein Outperform → Mkt Perform
2021-12-09 Ripresa Wells Fargo Overweight
2021-12-07 Ripresa Cowen Market Perform
2021-12-06 Iniziato Goldman Buy
2021-11-19 Ripresa BMO Capital Markets Outperform
2021-11-05 Downgrade The Benchmark Company Buy → Hold
2021-06-29 Iniziato H.C. Wainwright Buy
2021-01-25 Aggiornamento BMO Capital Markets Market Perform → Outperform
2021-01-13 Aggiornamento The Benchmark Company Hold → Buy
2021-01-08 Aggiornamento Citigroup Neutral → Buy
2020-10-05 Aggiornamento Cantor Fitzgerald Neutral → Overweight
2020-08-20 Downgrade The Benchmark Company Buy → Hold
2020-07-09 Aggiornamento SunTrust Hold → Buy
2020-05-26 Aggiornamento Wells Fargo Equal Weight → Overweight
2020-04-28 Downgrade Citigroup Buy → Neutral
2020-04-17 Aggiornamento The Benchmark Company Hold → Buy
2020-04-08 Iniziato The Benchmark Company Hold
2020-03-31 Iniziato Wolfe Research Peer Perform
2020-02-27 Iniziato Barclays Overweight
2020-02-26 Aggiornamento Canaccord Genuity Hold → Buy
2020-02-26 Downgrade Robert W. Baird Outperform → Neutral
2020-02-25 Aggiornamento Jefferies Hold → Buy
2020-02-11 Aggiornamento Argus Hold → Buy
2019-12-24 Iniziato Raymond James Mkt Perform
2019-12-16 Downgrade Evercore ISI Outperform → In-line
2019-12-13 Aggiornamento Credit Suisse Neutral → Outperform
2019-11-12 Iniziato SunTrust Hold
2019-11-07 Aggiornamento Citigroup Neutral → Buy
2019-10-17 Ripresa BofA/Merrill Neutral
2019-09-23 Aggiornamento Guggenheim Neutral → Buy
Mostra tutto

Regeneron Pharmaceuticals Inc Borsa (REGN) Ultime notizie

pulisher
06:43 AM

Aspire Growth Partners LLC Makes New $421,000 Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

06:43 AM
pulisher
05:57 AM

Mercer Global Advisors Inc. ADV Has $16.66 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

05:57 AM
pulisher
05:15 AM

Retinal Vein Occlusion Market Size, Trends & Growth Forecast - openPR.com

05:15 AM
pulisher
12:58 PM

Regeneron Pharmaceuticals (NASDAQ:REGN) Shares Gap Down After Earnings Miss - MarketBeat

12:58 PM
pulisher
May 04, 2025

TD Waterhouse Canada Inc. Lowers Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

May 04, 2025
pulisher
May 04, 2025

Voleon Capital Management LP Acquires Shares of 671 Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

May 04, 2025
pulisher
May 04, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Position Increased by The Manufacturers Life Insurance Company - MarketBeat

May 04, 2025
pulisher
May 04, 2025

Regeneron Pharmaceuticals (NASDAQ:REGN) Issues Quarterly Earnings Results, Misses Estimates By $0.61 EPS - MarketBeat

May 04, 2025
pulisher
May 03, 2025

Northern Trust Corp Has $751.39 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

May 03, 2025
pulisher
May 03, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Bought by Caisse DE Depot ET Placement DU Quebec - MarketBeat

May 03, 2025
pulisher
May 03, 2025

Sanofi & Regeneron's Dupixent Receives FDA Nod for Urticaria - MSN

May 03, 2025
pulisher
May 03, 2025

Cantor Fitzgerald Issues Positive Outlook for REGN Earnings - MarketBeat

May 03, 2025
pulisher
May 03, 2025

Westbourne Investments Inc. Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

May 03, 2025
pulisher
May 03, 2025

Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Lowered to “Hold” at StockNews.com - Defense World

May 03, 2025
pulisher
May 02, 2025

Regeneron (REGN) Declares Quarterly Dividend of $0.88/Share - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Retinal Vein Occlusion Market Projected To Witness Massive - openPR.com

May 02, 2025
pulisher
May 02, 2025

Schonfeld Strategic Advisors LLC Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

May 02, 2025
pulisher
May 02, 2025

AQR Capital Management LLC Sells 18,449 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

May 02, 2025
pulisher
May 02, 2025

Amgen’s Aflibercept Starts Strong As Regeneron Counts Cost Of Eylea Competition - insights.citeline.com

May 02, 2025
pulisher
May 02, 2025

FY2025 EPS Estimates for REGN Raised by Cantor Fitzgerald - Defense World

May 02, 2025
pulisher
May 02, 2025

Regeneron announces significant expansion of US manufacturing capacity - The Manufacturer

May 02, 2025
pulisher
May 02, 2025

Aquatic Capital Management LLC Grows Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

May 02, 2025
pulisher
May 01, 2025

Regeneron Pharmaceuticals (NasdaqGS:REGN) To Showcase Oncology And Respiratory Data At Major Conferences - simplywall.st

May 01, 2025
pulisher
May 01, 2025

Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘Arguably The Most Innovative Biopharma Company I’ve Seen In The Last Two Decades’ - MSN

May 01, 2025
pulisher
May 01, 2025

Regeneron Pharmaceuticals (REGN) Price Target Lowered by Guggenh - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Regeneron ordered to face lawsuit alleging Medicare fraud over Eylea - Seeking Alpha

May 01, 2025
pulisher
May 01, 2025

Thyroid Eye Disease Pipeline 2025: MOA, ROA, and Clinical Trial - openPR.com

May 01, 2025
pulisher
May 01, 2025

Regeneron to present new cancer treatment data at ASCO By Investing.com - Investing.com India

May 01, 2025
pulisher
May 01, 2025

Regeneron to present new cancer treatment data at ASCO - Investing.com

May 01, 2025
pulisher
May 01, 2025

Regeneron (REGN) to Unveil Key Oncology and Hematology Data at A - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Regeneron (REGN) to Showcase Dupixent Data at 2025 ATS Conferenc - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Regeneron (REGN) Faces Price Target Cut Amid Revenue Concerns | - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Regeneron (REGN) Faces Price Target Cut Amid Revenue Concerns | REGN Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Regeneron Pharmaceuticals to Present New Oncology and Hematology Data at 2025 ASCO Annual Meeting - Nasdaq

May 01, 2025
pulisher
May 01, 2025

Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases - Stock Titan

May 01, 2025
pulisher
May 01, 2025

PDT Partners LLC Grows Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

May 01, 2025
pulisher
May 01, 2025

Regeneron (REGN) Faces Price Target Cut Amid Eylea Challenges | - GuruFocus

May 01, 2025
pulisher
May 01, 2025

California State Teachers Retirement System Trims Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

May 01, 2025
pulisher
May 01, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Public Employees Retirement Association of Colorado - MarketBeat

May 01, 2025
pulisher
May 01, 2025

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Beacon Pointe Advisors LLC - MarketBeat

May 01, 2025
pulisher
May 01, 2025

Stifel Financial Corp Has $27.13 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

May 01, 2025
pulisher
Apr 30, 2025

MML Investors Services LLC Purchases 2,218 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat

Apr 30, 2025
pulisher
Apr 30, 2025

Jim Cramer Listed 20 Best Performing Stocks of the Last 20 Years - Insider Monkey

Apr 30, 2025
pulisher
Apr 30, 2025

Cantor Fitzgerald maintains Regeneron stock with $695 target By Investing.com - Investing.com South Africa

Apr 30, 2025
pulisher
Apr 30, 2025

Robert W. Baird Has Lowered Expectations for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price - MarketBeat

Apr 30, 2025
pulisher
Apr 30, 2025

Another Regeneron CRL Prompts Regulatory Operations Questions - insights.citeline.com

Apr 30, 2025
pulisher
Apr 30, 2025

Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 30, 2025
pulisher
Apr 30, 2025

Regeneron Shares Are Up Today: What's Going On? - Benzinga

Apr 30, 2025
pulisher
Apr 30, 2025

Guggenheim Cuts Regeneron Pharmaceuticals' Price Target to $810 From $940 - marketscreener.com

Apr 30, 2025
pulisher
Apr 30, 2025

Regeneron's Portfolio Still Supports a Narrow Moat Despite Competitive Threats to Eylea - Morningstar

Apr 30, 2025

Regeneron Pharmaceuticals Inc Azioni (REGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$656.80
price up icon 1.17%
$269.72
price up icon 3.90%
biotechnology ONC
$253.49
price down icon 0.78%
$104.51
price down icon 1.37%
$27.86
price up icon 0.04%
Capitalizzazione:     |  Volume (24 ore):